Home › Terpenes › Beta-Caryophyllene
⚐ Flag an error How this page was made
Also known as: β-caryophyllene · BCP · trans-caryophyllene · (−)-β-caryophyllene

Beta-Caryophyllene

A peppery sesquiterpene common in cannabis that binds the CB2 receptor, making it unusual among plant terpenes.

Sourced and fact-checked
9 cited sources
Published 1 week ago
How this page was made
↯ The honest take

Beta-caryophyllene is genuinely interesting because it's the rare terpene that acts like a cannabinoid — it binds CB2 receptors. That's real, peer-reviewed pharmacology, not marketing. But most of the exciting claims (anti-inflammatory, anxiolytic, neuroprotective) come from rodent studies and cell cultures. Human clinical trials on isolated BCP are thin on the ground. Treat it as a promising molecule with a solid mechanism, not a proven medicine. And no, sniffing black pepper does not reliably 'reset' a cannabis high — that's folklore.

What it is

Beta-caryophyllene (BCP) is a bicyclic sesquiterpene — a 15-carbon molecule (C15H24) built from three isoprene units. Unlike the more common monoterpenes in cannabis (myrcene, limonene, pinene), it has a heavier molecular structure and a much higher boiling point, around 262–264 °C [1]. It also contains an unusual cyclobutane ring, which is chemically rare among natural products.

What makes BCP genuinely notable is pharmacology, not just chemistry. In 2008, Gertsch and colleagues showed that BCP binds selectively to the CB2 cannabinoid receptor as a full agonist Strong evidence[2]. That makes it a 'dietary cannabinoid' — a plant terpene that talks directly to the endocannabinoid system, without touching CB1 (so no intoxication).

Where it's found

BCP is one of the most widely distributed sesquiterpenes in the plant kingdom. High concentrations occur in black pepper (Piper nigrum), clove (Syzygium aromaticum), hops (Humulus lupulus, cannabis's closest cultivated relative), rosemary, oregano, basil, and cinnamon leaf oil [3].

In cannabis, BCP is typically the dominant sesquiterpene, often present at 0.05–1.5% of total flower mass in dried material, though some chemotypes push higher. It tends to co-occur with its oxidized derivative caryophyllene oxide (the compound drug-detection dogs are trained on) and with humulene, a structurally related sesquiterpene [4].

Aroma and sensory profile

BCP smells peppery and spicy, with woody and faintly clove-like undertones. If a cannabis flower has an unmistakable black-pepper bite when you crack it open, BCP is usually responsible. Because it's a sesquiterpene, it's less volatile than monoterpenes — it lingers longer in cured flower and concentrates, and it survives moderate heat better than, say, myrcene or pinene. This is one reason cured cannabis often smells 'spicier' than fresh, as lighter terpenes evaporate first.

Effects research: what's real, what's preclinical

Confirmed mechanism. BCP is a selective CB2 agonist with a Ki of about 155 nM in mice Strong evidence[2]. CB2 receptors are concentrated in immune tissue and peripheral nerves, which is why BCP is investigated for inflammation and pain rather than intoxication.

Preclinical findings. In rodent models, BCP has shown anti-inflammatory effects (reduced cytokine release, less edema), analgesic effects in neuropathic and inflammatory pain models, anxiolytic and antidepressant-like behavior, and neuroprotective activity in stroke and neurodegeneration models [evidence:strong for animal data][5][6]. There is also preclinical evidence for reduced alcohol intake in mice via CB2 signaling Weak / limited[7].

Human evidence. This is where honesty matters. Controlled human trials of isolated BCP are sparse. Most human data on 'caryophyllene' comes from clove oil or copaiba oil preparations used topically, or from whole-plant cannabis where BCP is one of dozens of active compounds. Claims that BCP alone reliably treats anxiety, chronic pain, or addiction in humans are not yet supported by robust clinical trials Weak / limited.

The 'black pepper trick.' Neil Young popularized chewing black peppercorns to counter cannabis-induced anxiety, and Ethan Russo cited it in his 2011 entourage-effect paper [8]. It's plausible via CB2 modulation, but there's no controlled trial. File under Anecdote.

Cannabis cultivars high in BCP

Chemotype varies hugely between grows, so treat cultivar lists as tendencies, not guarantees. Cultivars commonly reported as BCP-dominant or BCP-rich in commercial lab panels include GSC (Girl Scout Cookies) and its descendants, Bubba Kush, Sour Diesel, Original Glue (GG4), Chemdawg, Candyland, and Skywalker OG Weak / limited[9]. If you actually care about the terpene, read the certificate of analysis for the specific batch — cultivar name alone is a poor predictor.

One useful heuristic: cultivars that smell distinctly peppery, spicy, or 'funky-fuel' rather than sweet-citrus or piney often lean BCP-heavy. The nose is more reliable than the name.

For context on how terpenes interact with cannabinoids, see Entourage Effect — a real research topic, but one with more hype than hard data.

Sources

  1. Peer-reviewed Sköld, M., Karlberg, A. T., Matura, M., & Börje, A. (2006). The fragrance chemical β-caryophyllene—air oxidation and skin sensitization. Food and Chemical Toxicology, 44(4), 538–545.
  2. Peer-reviewed Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J. Z., Xie, X. Q., Altmann, K. H., Karsak, M., & Zimmer, A. (2008). Beta-caryophyllene is a dietary cannabinoid. PNAS, 105(26), 9099–9104.
  3. Peer-reviewed Sharma, C., Al Kaabi, J. M., Nurulain, S. M., Goyal, S. N., Kamal, M. A., & Ojha, S. (2016). Polypharmacological properties and therapeutic potential of β-caryophyllene: a dietary phytocannabinoid of pharmaceutical promise. Current Pharmaceutical Design, 22(21), 3237–3264.
  4. Peer-reviewed Booth, J. K., & Bohlmann, J. (2019). Terpenes in Cannabis sativa – From plant genome to humans. Plant Science, 284, 67–72.
  5. Peer-reviewed Bahi, A., Al Mansouri, S., Al Memari, E., Al Ameri, M., Nurulain, S. M., & Ojha, S. (2014). β-Caryophyllene, a CB2 receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. Physiology & Behavior, 135, 119–124.
  6. Peer-reviewed Klauke, A. L., Racz, I., Pradier, B., Markert, A., Zimmer, A. M., Gertsch, J., & Zimmer, A. (2014). The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain. European Neuropsychopharmacology, 24(4), 608–620.
  7. Peer-reviewed Al Mansouri, S., Ojha, S., Al Maamari, E., Al Ameri, M., Nurulain, S. M., & Bahi, A. (2014). The cannabinoid receptor 2 agonist, β-caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice. Pharmacology Biochemistry and Behavior, 124, 260–268.
  8. Peer-reviewed Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364.
  9. Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.

How this page was made

Generation history

Jul 12, 2026
Fact-check pass — raised 2 flags
Jul 12, 2026
Initial draft

Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.